Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)
Loading...
Embargo End Date
ICR Authors
Authors
Heinrich, MC
Jones, RL
von Mehren, M
Schoffski, P
Serrano, C
Kang, Y-K
Cassier, PA
Mir, O
Eskens, F
Tap, WD
Rutkowski, P
Chawla, SP
Trent, J
Tugnait, M
Evans, EK
Lauz, T
Zhou, T
Roche, M
Wolf, BB
Bauer, S
George, S
Jones, RL
von Mehren, M
Schoffski, P
Serrano, C
Kang, Y-K
Cassier, PA
Mir, O
Eskens, F
Tap, WD
Rutkowski, P
Chawla, SP
Trent, J
Tugnait, M
Evans, EK
Lauz, T
Zhou, T
Roche, M
Wolf, BB
Bauer, S
George, S
Document Type
Journal Article
Date
2020-09-01
Date Accepted
2021-06-09
Abstract
Citation
The Lancet Oncology, 2020, 21 (9), pp. E418 - E418
DOI
Source Title
The Lancet Oncology
Publisher
ELSEVIER SCIENCE INC
ISSN
1470-2045
eISSN
1474-5488
1474-5488
1474-5488